TGS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.64959959423084E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.40699996098448E-09 |
Normal-vs-Stage2 |
7.31439997458949E-09 |
Normal-vs-Stage3 |
2.6723001589346E-10 |
Normal-vs-Stage4 |
2.59629995280619E-09 |
Stage1-vs-Stage2 |
6.895200E-01 |
Stage1-vs-Stage3 |
2.060200E-01 |
Stage1-vs-Stage4 |
6.370000E-01 |
Stage2-vs-Stage3 |
5.949000E-01 |
Stage2-vs-Stage4 |
9.927000E-01 |
Stage3-vs-Stage4 |
5.545400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.67210048427091E-10 |
Normal-vs-AfricanAmerican |
5.11250042301015E-10 |
Normal-vs-Asian |
6.216000E-02 |
Caucasian-vs-AfricanAmerican |
3.017600E-01 |
Caucasian-vs-Asian |
4.169600E-01 |
AfricanAmerican-vs-Asian |
2.839200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.37900033006611E-10 |
Normal-vs-Female |
3.21060000807449E-09 |
Male-vs-Female |
1.723620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.23369999561041E-08 |
Normal-vs-Age(41-60Yrs) |
6.55939969007591E-10 |
Normal-vs-Age(61-80Yrs) |
8.99910035379037E-10 |
Normal-vs-Age(81-100Yrs) |
2.25670000020273E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.288200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.629600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.016200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.395800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.706400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.903200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.625000E-04 |
Normal-vs-Grade 2 |
6.12069994687658E-09 |
Normal-vs-Grade 3 |
3.263200820669E-11 |
Normal-vs-Grade 4 |
2.42150000051566E-09 |
Grade 1-vs-Grade 2 |
2.189600E-01 |
Grade 1-vs-Grade 3 |
8.261700E-03 |
Grade 1-vs-Grade 4 |
1.191990E-01 |
Grade 2-vs-Grade 3 |
2.522400E-03 |
Grade 2-vs-Grade 4 |
1.876380E-01 |
Grade 3-vs-Grade 4 |
5.801000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.87010001612742E-09 |
Normal-vs-ccB subtype |
8.83069950496917E-10 |
ccA subtype-vs-ccB subtype |
1.669810E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.73770031486731E-10 |
Normal-vs-N1 |
9.517100E-03 |
N0-vs-N1 |
2.782800E-01 |
|
|